Filing Details
- Accession Number:
- 0001213900-21-003296
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-20 20:36:05
- Reporting Period:
- 2021-01-15
- Accepted Time:
- 2021-01-20 20:36:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1733413 | Tff Pharmaceuticals Inc. | TFFP | Pharmaceutical Preparations (2834) | 824344737 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1790624 | Allen Kirk Coleman | 2600 Via Fortuna, Suite 360 Austin TX 78746 | Cfo, Secretary And Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-01-15 | 5,000 | $2.50 | 6,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-15 | 5,000 | $17.50 | 1,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2021-01-15 | 5,000 | $0.00 | 5,000 | $2.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 287,883 | 2020-04-11 | 2029-04-11 | No | 4 | M | Direct |
Footnotes
- The transactions reported by this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2020.
- The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options.
- 37,500 shares of common stock vested on April 11, 2020 and the remainder of the shares vested at an approximate rate of 9,375 every three months thereafter.
Billionaire Hedge Funds
